Researchers work to bridge the gap between Chinese and Western medicine

October 8, 2012

When it comes to minor complaints, chronic conditions and even fatal illnesses, we often turn to ginseng and other herbal remedies. That is why traditional Chinese medicine has become an integral part of our life. But how many of us really know the effectiveness of these Chinese medicines from various sources?

A team of scientists from The Hong Kong Polytechnic University (PolyU) has been working on a new approach to drug development involving chemistry, biotechnology, mathematics, computer power and 5000-year ancient practices in . The groundbreaking regime for herbal study and testing called quantitative-pattern-activity-relationship ("QPAR" in short) verifies the quality and health benefits of traditional herbs. While Western pharmacology focuses on purified such as Vitamin C, Prof. Chau Foo Tim from the Department of Applied Biology and Chemical Technology and Dr Daniel Sze from the Department of Health Technology and Informatics studied the impact from a mix of compounds, a unique property in herbs.

"Information-rich pattern called chromatographic fingerprint were used to prove the authenticity of a medicinal plant. Our research team has further utilized the 'big data' three dimensional (3D) fingerprints to give a good presentation of active ingredients and bioactivities that allow scientists to excavate any healing power from a mix of compounds," said Prof. Chau.

To further bridge the gap between Chinese and Western medicines, Prof. Chau and Dr Sze have been working on a completely new drug classification and rating standard to establish a scientific link between traditional herbs and various diseases. The new QPAR standard for the first time links medicinal properties to cells, genes and proteins that trigger or contribute to a disease. For example, the magic fungus Ganoderma (靈芝) could be investigated for its ability to improve immunity by stimulating and therefore cell-mediated immune responses in our body.

"This is an innovative framework that quantifies the effect of traditional herbs would have on human health and common diseases on a sound scientific basis. QPAR can be used to verify how well Ganoderma can boost immunity and give a rating," said Dr Sze.

The research is still at an early stage but if successful, scientists will only have to do laboratory tests and crunch on computers to build databases, and get an accurate projection of active ingredients, efficacy and toxicity for preliminary herbal study in the future.

Another breakthrough is that QPAR uses mathematical methods to make predictions and the sophisticated algorithms tapped into 5000-year ancient system of Chinese medicine which was based on the flow and balance of positive (yang) and negative (yin) energies in the body. "We believed that blending the Chinese understanding of diseases into the western medicines would yield an approach more successful in unlocking the full potential of Chinese herbs," Dr Sze continued.

Dr Albert B. Wong, the founding president of the Modernised Chinese Medicine Association who was also a member of Hong Kong SAR Government's Panel on Promoting Testing and Certification Services in Chinese Medicine Trade, shared his views on this novel technique. "Health benefits of herbal remedies are widely known but not yet proven. People don't want to waste money or gamble on unproven treatments and then miss the chance of beating the diseases. New innovations are needed to bring transparency and credibility into herbal medicine."

Dr Wong also believed that this innovation would drive the evolution of herbal trade. "Herbs can be grown, hand-picked or collected. The quality of active ingredients and medicinal effects also varies with region, altitude, growing techniques and processing methods. QPAR provides a scientific way to quickly verify the authenticity and by different sources, making herbal trade fairer and more transparent. Drug companies would better control the prices and quality of raw herbs and also enforce standardisation and consistence across products. From the consumers' point of view, it is worth to spend the money on products that can give exactly what they want for their health benefits."

The unprecedented level of transparency will benefit the whole medical community. Practitioners of Chinese medicine, for example, can evaluate herbs more accurately and thus choose the most effective medication. Today, over three hundred herbs are commonly being used. It would be a long way before they become mainstream medicines. Drug discovery research is a long game which is expensive, complicated and time-consuming. QPAR could be a reliable and a relatively effective and efficient tool for pre-clinical funnelling so that scientists can narrow down the best plant candidates that warrant close scrutiny before clinical studies and applications. With PolyU's novel QPAR technique, the science of Chinese medicine will certainly move forward at a pace much faster than before.

Related Stories

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Chromodynamix
not rated yet Oct 09, 2012
Anything to reduce the medical quackery, which is piling up so fast, you need wings to stay above it.
However, this looks like science being used to incorrectly boost the credibilty of Chinese herbal remedies. As the article says, "Today, over three hundred herbs are commonly being used. It would be a long way before they become mainstream medicines."

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.